Logo image of CVEO

CIVEO CORP (CVEO) Stock Fundamental Analysis

USA - NYSE:CVEO - CA17878Y2078 - Common Stock

21.14 USD
+0.32 (+1.54%)
Last: 10/15/2025, 11:28:05 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CVEO. CVEO was compared to 84 industry peers in the Commercial Services & Supplies industry. While CVEO seems to be doing ok healthwise, there are quite some concerns on its profitability. CVEO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CVEO had negative earnings in the past year.
CVEO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CVEO reported negative net income in multiple years.
CVEO had a positive operating cash flow in each of the past 5 years.
CVEO Yearly Net Income VS EBIT VS OCF VS FCFCVEO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CVEO has a worse Return On Assets (-6.55%) than 70.24% of its industry peers.
The Return On Equity of CVEO (-15.91%) is worse than 64.29% of its industry peers.
Industry RankSector Rank
ROA -6.55%
ROE -15.91%
ROIC N/A
ROA(3y)0.56%
ROA(5y)-3.36%
ROE(3y)0.98%
ROE(5y)-6.71%
ROIC(3y)N/A
ROIC(5y)N/A
CVEO Yearly ROA, ROE, ROICCVEO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of CVEO has declined.
CVEO has a worse Gross Margin (21.53%) than 71.43% of its industry peers.
In the last couple of years the Gross Margin of CVEO has declined.
The Profit Margin and Operating Margin are not available for CVEO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.53%
OM growth 3Y-23.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-8.81%
CVEO Yearly Profit, Operating, Gross MarginsCVEO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

4

2. Health

2.1 Basic Checks

CVEO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVEO has been reduced compared to 1 year ago.
The number of shares outstanding for CVEO has been reduced compared to 5 years ago.
The debt/assets ratio for CVEO has been reduced compared to a year ago.
CVEO Yearly Shares OutstandingCVEO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CVEO Yearly Total Debt VS Total AssetsCVEO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CVEO has an Altman-Z score of -0.98. This is a bad value and indicates that CVEO is not financially healthy and even has some risk of bankruptcy.
CVEO has a Altman-Z score of -0.98. This is amonst the worse of the industry: CVEO underperforms 80.95% of its industry peers.
The Debt to FCF ratio of CVEO is 17.88, which is on the high side as it means it would take CVEO, 17.88 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CVEO (17.88) is comparable to the rest of the industry.
CVEO has a Debt/Equity ratio of 0.81. This is a neutral value indicating CVEO is somewhat dependend on debt financing.
CVEO has a Debt to Equity ratio (0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 17.88
Altman-Z -0.98
ROIC/WACCN/A
WACC8.43%
CVEO Yearly LT Debt VS Equity VS FCFCVEO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

CVEO has a Current Ratio of 1.51. This is a normal value and indicates that CVEO is financially healthy and should not expect problems in meeting its short term obligations.
CVEO has a Current ratio (1.51) which is comparable to the rest of the industry.
CVEO has a Quick Ratio of 1.45. This is a normal value and indicates that CVEO is financially healthy and should not expect problems in meeting its short term obligations.
CVEO's Quick ratio of 1.45 is in line compared to the rest of the industry. CVEO outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.45
CVEO Yearly Current Assets VS Current LiabilitesCVEO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CVEO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1664.29%.
CVEO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.60%.
The Revenue has been growing slightly by 5.27% on average over the past years.
EPS 1Y (TTM)-1664.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-101.79%
Revenue 1Y (TTM)-10.6%
Revenue growth 3Y4.69%
Revenue growth 5Y5.27%
Sales Q2Q%-13.79%

3.2 Future

CVEO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.64% yearly.
CVEO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.16% yearly.
EPS Next Y16.77%
EPS Next 2Y49.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.55%
Revenue Next 2Y-1.83%
Revenue Next 3Y-2.08%
Revenue Next 5Y1.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CVEO Yearly Revenue VS EstimatesCVEO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
CVEO Yearly EPS VS EstimatesCVEO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10

3

4. Valuation

4.1 Price/Earnings Ratio

CVEO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 70.66 indicates a quite expensive valuation of CVEO.
CVEO's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CVEO to the average of the S&P500 Index (22.99), we can say CVEO is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 70.66
CVEO Price Earnings VS Forward Price EarningsCVEO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than CVEO, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVEO indicates a somewhat cheap valuation: CVEO is cheaper than 64.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.13
EV/EBITDA 6.97
CVEO Per share dataCVEO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CVEO does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CVEO's earnings are expected to grow with 49.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.64%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.76%, CVEO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.41, CVEO pays a better dividend. On top of this CVEO pays more dividend than 92.86% of the companies listed in the same industry.
CVEO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 4.76%

5.2 History

CVEO has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CVEO Yearly Dividends per shareCVEO Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3

5.3 Sustainability

CVEO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-31.49%
EPS Next 2Y49.64%
EPS Next 3YN/A
CVEO Yearly Income VS Free CF VS DividendCVEO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

CIVEO CORP

NYSE:CVEO (10/15/2025, 11:28:05 AM)

21.14

+0.32 (+1.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-24 2025-10-24/bmo
Inst Owners79.66%
Inst Owner Change0%
Ins Owners5.14%
Ins Owner Change0.19%
Market Cap265.31M
Analysts85.71
Price Target28.05 (32.69%)
Short Float %2.34%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield 4.76%
Yearly Dividend1.02
Dividend Growth(5Y)N/A
DP-31.49%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-24 2025-02-24 (0.25)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.99%
Min EPS beat(2)11.4%
Max EPS beat(2)70.59%
EPS beat(4)2
Avg EPS beat(4)-406.35%
Min EPS beat(4)-1412.82%
Max EPS beat(4)70.59%
EPS beat(8)4
Avg EPS beat(8)-307.25%
EPS beat(12)5
Avg EPS beat(12)-216.08%
EPS beat(16)8
Avg EPS beat(16)557.39%
Revenue beat(2)0
Avg Revenue beat(2)-3.41%
Min Revenue beat(2)-4.67%
Max Revenue beat(2)-2.14%
Revenue beat(4)1
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-8.89%
Max Revenue beat(4)2.44%
Revenue beat(8)5
Avg Revenue beat(8)2.16%
Revenue beat(12)9
Avg Revenue beat(12)2.99%
Revenue beat(16)12
Avg Revenue beat(16)3.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-178.18%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.66
P/S 0.42
P/FCF 28.13
P/OCF 7.71
P/B 1.27
P/tB 2.06
EV/EBITDA 6.97
EPS(TTM)-2.19
EYN/A
EPS(NY)0.3
Fwd EY1.42%
FCF(TTM)0.75
FCFY3.55%
OCF(TTM)2.74
OCFY12.97%
SpS50.52
BVpS16.69
TBVpS10.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.55%
ROE -15.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.53%
FCFM 1.49%
ROA(3y)0.56%
ROA(5y)-3.36%
ROE(3y)0.98%
ROE(5y)-6.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-23.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-8.81%
F-Score3
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 17.88
Debt/EBITDA 2.83
Cap/Depr 36.58%
Cap/Sales 3.94%
Interest Coverage N/A
Cash Conversion 57.76%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.45
Altman-Z -0.98
F-Score3
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)36.55%
Cap/Depr(5y)27.78%
Cap/Sales(3y)4%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1664.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-101.79%
EPS Next Y16.77%
EPS Next 2Y49.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.6%
Revenue growth 3Y4.69%
Revenue growth 5Y5.27%
Sales Q2Q%-13.79%
Revenue Next Year-6.55%
Revenue Next 2Y-1.83%
Revenue Next 3Y-2.08%
Revenue Next 5Y1.16%
EBIT growth 1Y-129.89%
EBIT growth 3Y-20%
EBIT growth 5YN/A
EBIT Next Year865.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.15%
FCF growth 3Y-7.67%
FCF growth 5Y5.12%
OCF growth 1Y-60.9%
OCF growth 3Y-1.92%
OCF growth 5Y2.31%